Sympathetic Vascular Transduction Across the Menopause Transition: Contributing Mechanisms

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 10, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Menopause

Interventions

DRUG

Propranolol Hydrochloride

Examine how IV propranolol impacts sympathetic transduction

DRUG

Phentolamine Injection

Examine how IV phentolamine impacts sympathetic transduction

Trial Locations (1)

RECRUITING

University of Missouri, Columbia

All Listed Sponsors

lead

University of Missouri-Columbia

OTHER

NCT06787066 - Sympathetic Vascular Transduction Across the Menopause Transition: Contributing Mechanisms | Biotech Hunter | Biotech Hunter